Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Georgakoudi, I.
Right arrow Articles by Feld, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Georgakoudi, I.
Right arrow Articles by Feld, M. S.
[Cancer Research 62, 682-687, February 1, 2002]
© 2002 American Association for Cancer Research


Biochemistry and Biophysics

NAD(P)H and Collagen as in Vivo Quantitative Fluorescent Biomarkers of Epithelial Precancerous Changes1

Irene Georgakoudi2, Brian C. Jacobson, Markus G. Müller, Ellen E. Sheets, Kamran Badizadegan, David L. Carr-Locke, Christopher P. Crum, Charles W. Boone, Ramachandra R. Dasari, Jacques Van Dam and Michael S. Feld

G. R. Harrison Spectroscopy Laboratory, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 [I. G., M. G. M., C. W. B., R. R. D., M. S. F.]; Division of Gastroenterology, Department of Medicine [B. C. J., D. L. C-L., J. V. D.], Division of Gynecologic Oncology, Department of Obstetrics and Gynecology [E. E. S.], and Division of Women’s and Perinatal Pathology, Department of Pathology, Brigham & Women’s Hospital, Boston, Massachusetts 02115; and Department of Pathology [C. P. C.], Children’s Hospital, Boston, Massachusetts 02115 [K. B.]

During the development of neoplasia, epithelial tissues undergo biochemical and structural changes that can manifest in tissue fluorescence. There have been several reports on different in vivo fluorescence characteristics between normal and precancerous (dysplastic) tissues. However, it has been difficult to identify and quantify the origins of these changes, mainly because of distortions introduced in measured tissue fluorescence spectra by tissue scattering and absorption. Such distortions can be removed by combining information in simultaneously measured fluorescence and reflectance spectra. Thus, we can recover the intrinsic (undistorted) tissue fluorescence. In this report, we show that extraction of the intrinsic fluorescence allows us: (a) to determine the fluorescence spectra of NAD(P)H and collagen in an in vivo environment, and (b) to use these NAD(P)H and collagen spectra to describe, quantitatively, diagnostically significant biochemical changes between normal and dysplastic tissues. Specifically, by analyzing intrinsic fluorescence of human epithelial tissue as it becomes deoxygenated in vivo, we can resolve the fluorescence spectra of NAD(P)H and collagen, two of the major tissue fluorophores. This is important because fluorescence depends on the local environment of the chromophore. Then, we extract the intrinsic fluorescence spectra of sites from 35 patients with suspected cervical lesions and 7 patients with Barrett’s esophagus and describe them accurately as a linear combination of NAD(P)H and collagen contributions. In both tissue cases, we find that low collagen and high NAD(P)H fluorescence characterizes the high-grade dysplastic lesions when compared with nondysplastic tissues. These data present evidence for the presence of detectable levels of NAD(P)H fluorescence in human epithelial tissues in an in vivo setting and demonstrate that NAD(P)H and collagen may be used as quantitative fluorescence biomarkers for in vivo detection of dysplasia in the cervix and the esophagus.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
I. Pavlova, M. Williams, A. El-Naggar, R. Richards-Kortum, and A. Gillenwater
Understanding the Biological Basis of Autofluorescence Imaging for Oral Cancer Detection: High-Resolution Fluorescence Microscopy in Viable Tissue
Clin. Cancer Res., April 15, 2008; 14(8): 2396 - 2404.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. D. Kirkpatrick, M. A. Brewer, and U. Utzinger
Endogenous Optical Biomarkers of Ovarian Cancer Evaluated with Multiphoton Microscopy
Cancer Epidemiol. Biomarkers Prev., October 1, 2007; 16(10): 2048 - 2057.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R K Wali, H K Roy, Y L Kim, Y Liu, J L Koetsier, D P Kunte, M J Goldberg, V Turzhitsky, and V Backman
Increased microvascular blood content is an early event in colon carcinogenesis
Gut, May 1, 2005; 54(5): 654 - 660.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2002 by the American Association for Cancer Research.